Health Canada advised consumers not to use Khun-Phra promoted to treat arthritis and joint pain.

Small Bone Innovations's Artelon STT Spacer for early to mid-stage osteo-arthritis has been cleared by the FDA for marketing in the US.

A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus). These research findings result from a long-time collaboration between the Intramural Research Program (IRP) of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other organizations. NIAMS is part of the National Institutes of Health.

These results appear in the Sept. 6 issue of the New England Journal of Medicine.

A panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant part of the tool kit used in treating osteoarthritis (OA).

Results from the AMBITION trial successfully met its primary endpoint of non-inferiority in patients with moderheumatoid arthritiste to severe rheumatoid arthritis.

Rheumatoid arthritis affects 2.1 million Americans and despite many advances in the understanding of the disease, funds for research remain limited and both the cause and a cure are still unknown.

Three new drugs mark a new era for rheumatoid arthiritis treatment.

Even though more than two million Americans suffer from it, 40 percent of the nation's population does not realize gout is one of the most painful forms of arthritis.

If you're one of the estimated 395,000 Utah adults living with arthritis, now is the time to take action.

A new report revealed arthritis prevalence and activity limitations will increase substantially in all but two states and the District of Columbia by 2030.

A compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.

Arthritis and other rheumatic conditions exact a large and growing economic toll on the nation as a result of the increase in numbers of persons affected by Arthritis.

A variant in a gene called GDF5 is associated with the risk of developing osteoarthritis.

Arthritis pain is processed in brain areas concerned with emotions and fear, finds study, indicating target for pain-relieving therapies.

The publication of the Service Development and Commissioning Directives for Arthritis and Chronic Musculoskeletal Conditions is the result of work undertaken by a multi-agency and multi-professional group.